Cargando…
The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study
BACKGROUND: Thrombosis with thrombocytopenia syndrome (TTS) associated with viral vector COVID-19 vaccines, including ChAdOx1-S (AstraZeneca AZD1222) vaccine, can result in significant morbidity and mortality. We report the clinicopathological features of TTS following ChAdOx1-S vaccination and summ...
Autores principales: | Tran, Huyen A., Deng, Lucy, Wood, Nicholas, Choi, Philip, Singleton, Sally, Clarke, Lisa, Khanlari, Sarah, Maitland-Scott, Isis, Bird, Robert, Brown, Scott, Manoharan, Bavahuna, Tan, Chee Wee, Gold, Michael, Hissaria, Pravin, Melody, Shannon, Chunilal S, Sanjeev D., Buttery, Jim, Clothier, Hazel, Crawford, Nigel W., Phuong, Linny, Pepperell, Dominic, Effler, Paul, Parker, Claire, Carter, Nicola, Macartney, Kristine, McStea, Megan, Miller, Todd, Nissen, Michael, Larter, Claire, Kay, Elspeth, Chen, Vivien M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494168/ https://www.ncbi.nlm.nih.gov/pubmed/37701717 http://dx.doi.org/10.1016/j.lanwpc.2023.100894 |
Ejemplares similares
-
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia
por: Gordon, Sally F., et al.
Publicado: (2021) -
REATOGENICIDADE COM MEIA DOSE DA VACINA CHADOX1 NCOV-19 (AZD1222)
por: Gouvea, Maria da Penha Gomes, et al.
Publicado: (2022) -
Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia
por: Al Bahrani, Salma, et al.
Publicado: (2021) -
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai
por: Shetty, Arusha, et al.
Publicado: (2022) -
Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice
por: Stebbings, Richard, et al.
Publicado: (2021)